Je was op zoek naar: diagnosing (Engels - Maltees)

better diagnosing rare diseases; and
jidentifikaw aħjar il-mard rari; u

the patient plays a significant role in diagnosing and correcting hyperglycemia linked to pump performance problems.
il-pazjent għandu parti sinifikanti għall-fatt li jagħmel dijanjosi u jikkoreġi ipergliċemija marbuta ma’ problemi fil-funzjoni tal-pompa.

stelara is given under the supervision of a doctor who has experience in diagnosing and treating psoriasis.
stelara tingħata taħt superviżjoni ta ’ tabib li jkollu esperjenza fid- dijanjostikar u t- trattament tal - psorijażi.

access by the competent authority to laboratories with the facilities for diagnosing and differentiating listed and emerging diseases.
l-aċċess mill-awtorità kompetenti għal laboratorji bil-faċilitajiet biex jiddjanjostikaw u jiddistingwu l-mard elenkat u dak li qed jitfaċċa.

the main measure of effectiveness was the time it took for patients to develop ms, using standard criteria for diagnosing ms.
il-miżura ewlenija tal-effikaċja kien iż-żmien li ħadu l-pazjenti li jiżviluppaw l-sm, bl-użu ta’ kriterji standard għad-dijanjożi tal-sm.

consequently, local and regional bodies should be involved in diagnosing, designing, implementing and assessing actions.
għaldaqstant, il-korpi lokali u reġjonali għandhom ikunu involuti fl-analiżi, it-tħejjija, l-implimentazzjoni u l-evalwazzjoni ta’ l-azzjonijiet.

treatment with cimzia should only be started by a specialist doctor who has experience in diagnosing and treating the diseases that cimzia is used to treat.
il-kura b’cimzia għandha tinbeda biss minn tabib speċjalist li għandu l-esperjenza fid-dijanjożi u l-kura tal-mard li għalih jintuża cimzia.

when the results of both studies were looked at together, leukoscan was shown to be as effective in diagnosing bone infections as the biopsy and culture technique.
meta r-riżultati taż-żewġ studji ġew studjati flimkien, intwera li leukoscan huwa effettiv fid-djanjosi ta’ l-għadam daqs kemm hu effettiv fil-bijopsija u t-teknika tal-kultura.

whereas these substances must not be used in feeding-stuffs for the prime purpose of diagnosing, treating or preventing disease;
billi dawn is-sustanzi ma għandhomx jiġu użati f'għalf għall-bhejjem bl-iskop ewlieni ta' dijanjożi, trattament jew prevenzjoni ta' marda;

to coordinate, in consultation with the commission, the methods employed in the member states for diagnosing african horse sickness, specifically by:
biex jikkordina, flimkien mal-kummissjoni, l-metodi wżati fl-istati membri għad‑djanjożi tal-marda afrikana taż-żwiemel, speċifikatament minn:

4.3 we feel that patient care calls for coordination among the various levels of healthcare delivery, so that primary care plays a more prominent role in diagnosing and treating health problems.
4.3 il-kumitat iqis li l-kura tas-saħħa tal-pazjent għandha tkun ikkoordinata fost il-livelli kollha tal-kura, b'tali mod li r-rwol tal-kura primarja jkun aktar rilevanti fid-dijanjożi u l-kura tal-problemi tas-saħħa.

the main measure of effectiveness was the accuracy of diagnosing a malignant tumour (positive) or a benign tumour (negative).
il-kejl ewlieni ta’ l-effikaċja kienet il-preċiżjoni tad-dijanjożi ta’ tumur malinn (pożittiv) jew tumur beninn (negattiv).

the company that markets xiapex must also ensure that all doctors expected to use the medicine are properly trained on the use of the medicine and experienced in diagnosing and managing dupuytren’s contracture or peyronie’s disease.
il-kumpanija li tqiegħed xiapex fis-suq għandha tiżgura wkoll li t-tobba kollha li mistennija jużaw din il- mediċina huma mħarrġa sew dwar l-użu tal-mediċina u li għandhom l-esperjenza fid-dijanjożi u l- immaniġġjar tal-kontrazzjoni ta’ dupuytren jew il-marda ta’ peyronie.

in comparison with biopsy based techniques for diagnosing h. pylori infection, using data from two therapeutic trials, pylobactell achieved during different conditions (pre-study and follow-up visits) sensitivity estimates above 95% with lower one-sided 95% confidence limit ranging from 93% to 98%.
meta mqabbel ma’ tekniċi bbażati fuq il-bijopsija bħala dijanjożi għall-infezzjoni ta’ l-h. pylori u meta wieħed juża informazzjoni minn żewġ provi terapewtiċi, il-pylobactell –f’kondizzjoniet differenti (l-eżamijiet mediċi ta’ qabel ma’ beda l-istudju u dawk ta’ wara) - laħaq stimi tas-sensittività ta’ ’l fuq minn 95 % bil-lower one-sided 95 % confidence limit bejn 93 % sa 98 %.